CUMBERLAND PHARMACEUTICALS INC — Director's Dealing 2014

Mar 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK: 0001087294
Period of Report: 2014-03-21

Reporting Person: Pavliv Leo (SVP and Chief Development Off.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-21	Common Stock	A	5000	$4.58	Acquired	97695	Direct

Footnotes

F1: Restricted stock award will vest 100% on March 14, 2018.